1. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region 
K.B. Laupland, D.B. Gregson, D.L. Church, T. Ross, J.D.D. Pitout 
Clinical Microbiology and Infection 
Volume 14, Issue 11, Pages (November 2008)
DOI: /j x
Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Annual incidence of Escherichia coli bloodstream infections in the Calgary Health Region, Canada, 2000–2006. CA, community-acquired; HCA, healthcare-associated community-onset; NA, nosocomial-acquired.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

3. Fig. 2
Age-specific incidence of Escherichia coli bloodstream infections in the Calgary Health Region, Canada, 2000–2006.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

4. Fig. 3
Rates of antimicrobial resistance among Escherichia coli isolates from bloodstream infections in the Calgary Health Region, Canada, 2000–2006. TMP/SMX, trimethoprim–sulphamethoxazole.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions